Kamarashev J, Burg G, Mingari M C, Kempf W, Hofbauer G, Dummer R
Department of Dermatology, University Hospital, Zurich, Switzerland.
Am J Pathol. 2001 May;158(5):1593-8. doi: 10.1016/S0002-9440(10)64114-4.
Cutaneous lymphomas of the cytotoxic phenotype, including CD8+ and CD56+ lymphomas, have only recently been recognized. To characterize the phenotypic profile of these lymphomas, we investigated the expression of both cytotoxic molecules and killer cell inhibitory receptors by immunohistochemistry techniques. Frozen sections from four CD8+ and from three CD56+ cutaneous lymphomas were stained for the cytotoxicity markers including T-cell restricted intracellular antigen-1, perforin, granzyme B, and for expression of the inhibitory receptors including p58.1, p58.2, p70, p140, CD94, NKG2, and leukocyte immunoglobulin-like receptor (LIR-1). Apart from LIR-1, the CD8+ lymphomas in our series express p70 and p140 from the inhibitory receptors and only one or two of the cytotoxic proteins. The CD56+ lymphomas, on the other hand, express only LIR-1 of the set of inhibitory receptors and the whole panel of cytotoxic antigens. Various subtypes of cytotoxic cutaneous lymphomas (CD8+ and CD56+) differ in regard to their phenotypic and functional profile, which may explain differences in their biological behavior.
具有细胞毒性表型的皮肤淋巴瘤,包括CD8 +和CD56 +淋巴瘤,直到最近才被认识到。为了表征这些淋巴瘤的表型特征,我们通过免疫组织化学技术研究了细胞毒性分子和杀伤细胞抑制性受体的表达。对来自4例CD8 +皮肤淋巴瘤和3例CD56 +皮肤淋巴瘤的冰冻切片进行染色,检测细胞毒性标志物,包括T细胞限制性细胞内抗原-1、穿孔素、颗粒酶B,以及抑制性受体的表达,包括p58.1、p58.2、p70、p140、CD94、NKG2和白细胞免疫球蛋白样受体(LIR-1)。除LIR-1外,我们系列中的CD8 +淋巴瘤表达抑制性受体中的p70和p140,且仅表达一两种细胞毒性蛋白。另一方面,CD56 +淋巴瘤仅表达抑制性受体组中的LIR-1和全套细胞毒性抗原。细胞毒性皮肤淋巴瘤的各种亚型(CD8 +和CD56 +)在表型和功能特征方面存在差异,这可能解释了它们生物学行为上的差异。